Lyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal Officer

WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (“CRS”), today announced the appointment of Ronan O’Brien, as Chief Legal Officer, effective October 16, 2023.

 Read More

Related Post
Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.

 

BlogofInnovation.com

Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.

Recent Posts

NFL s Tennessee Titans add lifesavers to the chain of survival in 20 Nashville schools

​​NASHVILLE, Tenn., Dec. 11, 2024 — Representatives from 20 local Metro Nashville Public Schools (MNPS) joined the American Heart Association…

4 hours ago

Edupoint Honors Northshore School District (Wash.) as the Company’s 9th Annual ‘Partner for Life’

MESA, Ariz., Dec. 11, 2024 (SEND2PRESS NEWSWIRE) — Edupoint® Educational Systems, creator of the industry-leading Synergy® Education Platform for K-12…

5 hours ago

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners

​​FREMONT, Calif. - (NewMediaWire) - December 11, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions…

7 hours ago

HitPaw VikPea V4.0.0 Released with Major Updates including AI Color Module

NEW YORK, N.Y., Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — HitPaw, a leading software company, is excited to announce the new…

23 hours ago

Empowering Businesses and Notaries to Expand Their Reach with Cutting-Edge RON Technology

DALLAS, Texas, Dec. 10, 2024 (SEND2PRESS NEWSWIRE) — ProNotary, a pioneering force in the remote online notarization (RON) industry, today…

24 hours ago

Prevention, life-saving therapies, anti-obesity meds top 2024 heart, stroke research news

​​DALLAS, Dec. 10, 2024 — Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure,…

1 day ago

Seguici

Innovation Newsletter
Don't miss the most important news about Innovation. Sign up to receive them by email.